A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: harsh (4), strict (49), acute (409)

UHS Patient safety incident response plan

Description
Patient safety incident response plan Effective date: 2nd October 2023 Estimated refresh date:2nd October 2024 with inform
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Patient-safety-incident-response-plan.pdf

Tisacel - Cyclophosphamide (500) - Fludarabine (30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – TISACEL– CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) Regimen This regimen will only b
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Tisacel-Cyclophosphamide-500-Fludarabine-30-Ver1.pdf

Brexucel - Cyclophosphamide (900) - Fludarabine (25)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – BREXUCEL – CYCLOPHOSPHAMIDE (900) – FLUDARABINE (25) This regimen will only be avai
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Brexucel-Cyclophosphamide-900-Fludarabine-25.pdf

Tisacel -Cyclophosphamide (250)-Fludarabine (25)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY DLBCL/ FL – TISACEL – FLUDARABINE (25) – CYCLOPHOSPHAMIDE (250) Regimen This regimen will
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Tisacel-Cyclophosphamide-250-Fludarabine-25.pdf

InP-Cisplatin-Doxorubicin-Methotrexate (1-4)

Description
Chemotherapy Protocol Sarcoma CISPLATIN-DOXORUBICIN-METHOTREXATE (cycles 1-4) Inpatient Regimen There are multiple versio
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Cisplatin-Doxorubicin-Methotrexate-1-4.pdf

Capecitabine-Carboplatin(AUC5)-Cetuximab

Description
Chemotherapy Protocol HEAD AND NECK CANCER CAPECITABINE-CARBOPLATIN (AUC5)-CETUXIMAB Regimen • Head and Neck Cancer – Capecitabine-Carboplatin-Cetuxim
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Capecitabine-Carboplatin-Cetuximab.pdf

Papers Trust Board - 27 July 2023

Description
Date Time Location Chair Agenda Trust Board – Open Session 27/07/2023 9:00 - 13:15 Conference Room, Heartbeat/Microsoft Teams
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Papers-Trust-Board-27-July-2023.pdf

Carboplatin-Vinorelbine Oral

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-VINORELBINE (Oral) Regimen  NSCLC – Carboplatin (AUC6)-Vinorelbine (Oral
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-Oral.pdf

Going home after your stay at the major trauma centre - patient information

Description
This factsheet gives you useful information about returning home after your stay at the trauma centre.
Url
/Media/UHS-website-2019/Patientinformation/Major-Trauma-Centre/Going-home-after-your-stay-at-the-major-trauma-centre-3124-PIL.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Carboplatin (AUC5)-Paclitaxel (21 day) In
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/CarboplatinAUC5-Paclitaxel-21day.pdf
621 to 630 of 727
Previous … 61 62 63 64 65 … Next